Business Context and Reporting Period
This Form 8-K filing by Abbott Laboratories was submitted on February 17, 2006. The report details a corporate governance update regarding the compensation structure for non-employee directors, specifically addressing the Audit Committee.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report focused on a specific material agreement rather than a periodic financial statement.
Material Changes
The Board of Directors amended the Non-Employee Directors' Fee Plan, effective as of the 2006 Annual Meeting (April 28, 2006). The changes increase compensation for Audit Committee members to reflect increasing demands:
- Audit Committee Chairman: Monthly fee increased from $1,000 to $1,500.
- Audit Committee Members: Monthly fee set at $500 for each month of service.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future performance. No specific risks or contingencies are disclosed in this report other than the operational context of increased demands on the audit committee.
Investor Verification Checklist
- Verify the effective date of the fee increase (April 28, 2006).
- Review the attached Exhibit 10.1 for the full text of the amended Fee Plan.
- Confirm the total number of Audit Committee members to calculate the aggregate annual cost impact of this change.